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Summary
Objective: To determine the role of transforming growth factor 1 (TGF) in early calcium pyrophosphate formation by measuring its effects
on articular chondrocyte matrix vesicle (MV) formation, specific activity of the inorganic pyrophosphate(PPi)-generating enzyme nucleoside
triphosphate pyrophospho-hydrolase (NTPPPH) and biomineralization capacity.
Methods: MV elaborated from mature porcine chondrocyte monolayers±TGF were compared for protein content, NTPPPH activity, and
ATP-dependent biomineralization. Precipitation of calcium pyrophosphate mineral phases by MV was determined by a radiometric assay and
by Fourier transform infrared spectroscopy (FTIR).
Results: MV from monolayers exposed to TGF were enriched in NTPPPH activity compared to MV from control monolayers (P<0.01) and
precipitated more calcium/mg MV protein than controls (P≤0.01). FTIR spectra of mineral generated by monolayer-elaborated MV were
consistent with poorly crystalline CPPD.
Conclusions: TGF is capable of increasing the capacity of articular chondrocyte-derived MV to generate PPi via NTPPPH and precipitate
calcium in the form of CPPD mineral. These data support the concept that this growth factor plays a key role in cartilage matrix CPPD
deposition. © 2001 OsteoArthritis Research Society International
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One in three elderly persons develops calcium pyrophos-
phate dihydrate (CPPD) crystal deposition disease1. CPPD
crystals cause painful acute arthritic attacks and chronic
cartilage degeneration. CPPD deposition occurs most com-
monly as a sporadic idiopathic condition and may also be
seen following meniscal injury, in association with meta-
bolic diseases, and in certain kindred. Although the patho-
logic sequence leading to the formation of CPPD crystals is
uncertain, accumulation of excess extracellular inorganic
pyrophosphate (ePPi) is fundamental. Studies of patho-
genetic mechanisms in CPPD crystal formation have
focused on the chondrocyte as the most likely source of
ePPi that forms crystals. Transforming growth factor 1 is
the most potent known stimulus for ePPi elaboration189by chondrocytes2. and may play a role in CPPD crystal
formation.
CPPD crystals deposit in articular cartilage matrix when
ePPi complexes with calcium in a physiochemical milieu
conducive to crystal growth. Membrane-limited matrix ves-
icles (MV) provide such a potential protective environment
for promoting crystal growth within the cartilage matrix3.
MV derived from articular cartilage generate CPPD in the
presence of ATP in vitro4. Factors which regulate articular
cartilage MV formation and mineralization are unknown.
Articular cartilage MV are enriched in nucleoside triphos-
phate pyrophosphohydrolase (NTPPPH), which is capable
of generating ePPi from ATP and thereby fostering CPPD
crystal formation5. Synovial fluid and cartilage from joints
with CPPD deposition show higher NTPPPH activity than
those with osteoarthritis (OA) or inflammatory arthro-
pathies6,7. Articular cartilage MV may serve as a source
of ePPi-generating NTPPPH, distant from articular
chondrocytes and regulated by matrix growth factors.
TGF has been shown to up-regulate osteosarcoma
plasma cell membrane glycoprotein-1 (a form of NTPPPH)
expression8 as well as porcine articular chondrocyte2,
human articular chondrocyte9, and osteosarcoma MV
NTPPPH activity10. We sought to determine whether TGF
may favor CPPD formation by a mechanism beyond its
recognized property of stimulating ePPi elaboration by
chondrocytes2,11. We report that TGF increases
chondrocyte-derived MV NTPPPH specific activity and the
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CHONDROCYTE MONOLAYERS
Hyaline cartilage was shaved from the femoral condyles
of freshly slaughtered mature pigs and enzymatically
digested to release chondrocytes4. Chondrocytes were
plated at 2×105 cells/cm2 in 100 mm plates in 10 ml Dul-
becco’s Modified Eagles Media, Gibco (DMEM) containing
10% fetal bovine serum (FBS) and 1% penicillin-
streptomycin-Fungizone (PSF)2. Twenty-four hours later,
media was changed to 10 ml of one of four experimental
media: (1) serum-free DMEM containing 0.35 mg/ml bovine
serum albumin and 1% PSF (SF); (2) SF+10 ng/ml
TGF12, Astral (SF+TGF); (3) DMEM+1% PSF+10%
FBS that was heat-inactivated at 60°C for 45 min (to
inactivate inorganic pyrophosphatase in FBS) (HI); (4)
HI+10 ng/ml TGF (HI+TGF). Every 3 days media were
retrieved from monolayers for MV isolation and replenished
with the same type of fresh media. Five separate exper-
iments were performed.MV ISOLATION
Monolayer-extruded MV were isolated from conditioned
media by serial centrifugation; at 1171 g for 10 min to
remove intact cells, then at 20 000 g for 15 min to remove
large cell fragments and organelles, and finally at
200 000 g for 40 min to isolate MV5. MV were suspended
in Hank’s Balanced Salt Solution (HBSS) to a final
concentration of 1–10 mg protein/ml.NTPPPH SPECIFIC ACTIVITY
Suspended MV pellets were analysed for protein content
by the method of Lowry13. NTPPPH activity was measured
using 2 mM thymidine 5-monophosphate p-nitrophenol
ester, pH 7.45. All NTPPPH activities are expressed
as nmol substrate hydrolysed per hr/mg MV protein.
Determinations were performed in triplicate.ELECTRON MICROSCOPY
MV were isolated from chondrocyte monolayer media
(HI and SF) retrieved on day 6 by serial centrifugation at
1171 g for 10 min to remove intact cells, then at 200 000 g
for 40 min to pellet MV. MV were fixed in 2.5% glutaralde-
hyde in 0.1 M cacodylate buffer, pH 7.2–7.4. Specimens
were washed with veronal acetate buffer, pH 7.2; post-fixed
with 1% osmium tetroxide in veronal acetate buffer, pH 7.2,
and embedded in Polybed 812 (PolySciences, Warrington,
PA). Blocks were sectioned, placed on 200 mesh copper
grids, stained with uranyl acetate and Reynold’s lead citrate
and examined using a Philips 400 electron microscope
(Philips Electronic Instruments, Mahwah, NJ).MV BIOMINERALIZATION
MV calcium precipitation was assayed in a physiologic
calcifying salt solution (CSS) containing 2.2 mM Ca Cl2
1.6 mM KH2PO4, 1 mM MgCl2, 85 mM NaCl, 15 mM KCl,
10 mM NaHCO3, 50 mM N-tris(hydroxymethyl) methyl-2-
aminoethane sulfonic acid (Sigma), plus 1 mM ATP di-
sodium salt, 2% PSF, 0.2% gentamicin, and 1 Ci/ml 45Ca
(Amersham, Arlington Heights, IL), pH 7.614. A 25 l sus-
pension of MV was added to 500 l of the above solution
and incubated for 72 h at 37°C. MV-generated mineral was
then pelleted by centrifugation in a refrigerated microfuge
at 10 000 g for 10 min and twice washed with cold, un-
labeled CSS. 45Ca contained in the mineral phase was
solubilized with concentrated HCl and counted in 4 ml
scintillation fluid in a Minaxi Tri-Carb 4000 series scintilla-
tion counter (Packard, Downers Grove, IL). Determinations
were performed in triplicate. Results are expressed as mol
Ca precipitated/mg MV protein.FTIR SPECTROSCOPY
Mineralized MV were analysed as KBr pellets on a
Nicolet 520 FTIR spectrometer. Forty spectral scans were
computer averaged to produce each 4000–400 cm−1 FTIR
spectrum. Spectra of non-mineralized MV were consist-
ently subtracted from experimental spectra to a flat base-
line for protein peaks in order to discern the mineral phase.STATISTICS
The Wilcoxon signed rank and rank sum tests were used
to compare paired and grouped data, respectively. The
Spearman rank correlation was used to test the association
of two continuous variables. Results are expressed as
mean±S.D. unless otherwise specified.Results
EM showed that membrane-bound vesicles were iso-
lated from chondrocyte monolayer media. Three popula-
tions of MV measuring 66±12 nm (N=50), 126±17 nm
(N=25) and 203±34 nm (N=24) were retrieved from the
conditioned media of monolayers from day 3 through 6
(Fig. 1). These MV sizes were consistent with those
reported in chick epiphyses15. When the MV isolation
procedure for EM included the 20 000 g spin, MV in
subsequent pellets were too dispersed to quantify.
TGF did not affect the protein content of media-derived
MV fractions. There were no significant differences
between the mean protein contents of the MV fractions
derived from monolayers exposed to TGF compared to
their respective unexposed controls for either media type.
HI media-derived MV fractions possessed higher mean
protein contents than those of parallel SF media-derived
MV [HI+TGF vs SF+TGF, (P<0.01, N=14), HI vs SF,
(P<0.01, N=14)].
TGF increased the specific activity of media-derived
MV NTPPPH. Monolayers exposed to TGF elaborated MV
with approximately twice the NTPPPH activity as MV from
control monolayers in either media type [HI+TGF vs HI
(P<0.01, N=14), SF+TGF vs SF (P<0.01, N=14)] (Fig.
2). NTPPPH-specific activities did not progressively
increase over the three time points for either TGF or
control media MV. NTPPPH activities of MV derived fromsubsequent capacity to form CPPD mineral. Thus,
TGF promotes CPPD formation both by stimulating
chondrocyte ePPi formation and by altering the compos-
ition of chondrocyte-derived MV so as to favor ePPi forma-
tion. Future studies into the pathogenesis of CPPD
formation should consider both of these bioregulated pro-
cesses, chondrocyte ePPi generation and qualitative
changes in MV.


























Day 6 Day 9
Fig. 2. The effect of TGF on MV NTPPPH specific activity. The
results of a representative experiment show that exposure of
chondrocyte monolayers to TGF (10 ng/ml) every 3 days for a
total of 9 days yielded conditioned media MV with increased
NTPPPH-specific activity compared to MV from control mono-
layers. Specific activity=nmol per hr/mg MV protein. SF=MV
isolated from serum free media, HI=MV isolated from media
containing heat-inactivated FBS. Bars show mean and S.D. (N=3).Table I










The results of a representative experiment at day 9 showed that
MV NTPPPH specific activities were significantly higher than the
respective final supernatant of the 200 000 g spin for all conditions
tested. Specific activity=nmol per hr/mg MV protein. HI=MV iso-
lated from conditioned media containing heat-inactivated FBS.
SF=MV isolated from serum-free conditioned media. Data is

























Day 6 Day 9
Fig. 3. The effect of TGF on MV biomineralization. The results of
a representative experiment show that exposure of chondrocyte
monolayers to TGF (10 ng/ml) every 3 days for a total of 9 days
yielded conditioned media MV capable of sustaining higher
calcium precipitation/mg MV protein than MV from control mono-
layers. SF=MV isolated from serum free media, HI=MV isolated
from media containing heat-inactivated FBS. Bars show
mean±S.D., N=3.SF media were an average of 5× higher than their
HI-media counterparts [SF+TFG vs HI+TGF (P<0.01,
N=14), SF vs HI (P<0.01, N=14)]. This difference may be
explained by HI media MV having an average of a 4–5×
higher Lowry protein content. It is not known whether the
higher protein content of HI media MV is due to an increase
in the number or size of MV or to an increase in other
non-MV pellet proteins. MV exposed to SF media with or
without TGF possessed NTPPPH activities comparable to
previously reported MV derived from porcine cartilage
digest (PMV)5.
Media-derived MV were enriched in NTPPPH compared
to their resultant supernatants. Media-derived MV isolated
at 200 000 g possessed an average of 23× higher
NTPPPH SAs (range 2–115) than the corresponding
200 000 g supernatant in each of the four experimental
conditions for each of the three time points (P<0.01, N=12)
(Table I).TGF increased calcium precipitation by media-derived
MV. MV derived from media of monolayers exposed to
TGF precipitated more calcium/mg protein than MV from
control monolayers for all time points, in all experiments, in
either media type [SF vs SF+TGF (P<0.01, N=12), HI vs
HI+TGF (P=0.01, N=12)]. MV from monolayers exposed
to SF+TGF precipitated more calcium/mg protein than
those from HI+TGF exposed monolayers (P<0.01, N=12)
(Fig. 3). MV isolated from SF media showed a trend toward
higher biomineralization than their HI-media counterparts
(P=0.1, N=12). There was a positive correlation between
media-derived MV biomineralization and NTPPPH activity
(P<0.001, N=49).
Media-derived MV biomineralization did not significantly
differ from that of articular cartilage digest MV. Figure 3
compares mean calcium precipitation/mg protein of media-
derived MV with that of PMV and human osteoarthritic
cartilage digest MV (OAMV). Media-derived MV showed
greater interexperimental variation in calcium precipitation
192 B. A. Derfus et al.: TGF-1 increases MV biomineralizationthan cartilage digest MV. In these studies, MV from mono-
layers exposed to SF media±TGF precipitated amounts
of calcium/mg protein similar to that of previously described
PMV derived from porcine articular cartilage digest (Fig. 4).
Further, HI media MV calcium precipitation was similar to
that of OAMV16.
FTIR spectra of mineral made by media-derived MV
showed immature CPPD. FTIR spectroscopic analysis
enabled identification of the mineral phase generated by
MV isolated from HI-TGF monolayer media (Fig. 5). The
absorbances at 915 and 745 cm−1 were characteristic of a
P–O–P vibration, consistent with the infrared spectrum of
CPPD. The lack of resolution of the broad absorbance in
the 450–650 cm−1 region suggests that the CPPD formed
was a poorly crystalline mineral phase. It also appeared
that some residual CSS may be present, based on the


























Fig. 4. Comparison of media and digest MV biomineralization.
There are no significant differences between calcium precipitation
for MV derived from SF media vs porcine cartilage digest MV or
between that of MV derived from HI media vs human OA cartilage
digest. SF=MV isolated from serum free media (N=12, each bar).
HI=MV isolated from media containing heat-inactivated FBS
(N=12, each bar). PMV=MV isolated from porcine articular carti-
lage digest (N=7). OAMV=MV associated from human OA
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Fig. 5. The FTIR spectrum of mineral generated by MV isolated
from HI+TGF monolayer media in an ATP-dependent biominer-
alization assay.Discussion
We have demonstrated that MV isolated from the culture
media of articular chondrocytes exposed to TGF pos-
sessed higher NTPPPH activity and precipitated more
calcium/mg protein than MV elaborated by chondrocytes
which were not exposed to TGF. ePPi generated by MVcould serve as both an inhibitor of matrix apatite deposition
and as the anionic component of CPPD crystals. Media-
derived MV are the least perturbed vesicle preparation
available for study of modifiers of chondrocyte metab-
olism17. Our work confirmed that MV derived from serum-
free conditioned media were comparable to previously
reported articular cartilage digest MV with respect to size,
NTPPPH activity and ATP-dependent biomineralization.
This study showed that articular chondrocytes exposed
to TGF elaborated MV with higher NTPPPH activity
than those of unexposed chondrocytes. MV-associated
NTPPPH may provide a source for the generation of ePPi
in the matrix distant from chondrocytes. An increase in MV
NTPPPH activity could increase breakdown of low but
constantly replenished extracellular synovial fluid ATP18,
perhaps yielding sufficient ePPi to prevent the growth of
apatite crystals in cartilage matrix more distant from
chondrocytes. MV from normal human cartilage possess
3× the NTPPPH activity compared to MV from OA human
cartilage supporting a role for MV in preventing apatite
deposition in normal cartilage matrix19. TGF-induced
increased MV NTPPPH activity demonstrates this growth
factor’s potential to enhance protection against apatite
growth at sites distant from chondrocytes.
We previously reported that TGF doubled the NTPPPH
activity of unfractioned conditioned media from porcine
cartilage organ culture2. MV may be the media component
responsible for this increase. The specific location of
NTPPPH within cartilage matrix may determine whether its
product ePPi precipitates with calcium. Excess ePPi gen-
erated by MV NTPPPH places this anion at a location
theoretically distant from cellular pyrophosphatases and
near MV membranes that possess a unique phospholipid
profile rich in calcium-binding phosphatidylserine and
potentially enriched in other calcium binding proteins20,21.
Within a milieu of degenerating matrix, TGF’s effect on
MV could favor calcium pyrophosphate deposition. Our
biomineralization assay revealed a dramatic increase in
calcium precipitation by MV derived from TGF-exposed
chondrocytes. FTIR spectra suggested that this mineral is
poorly crystalline CPPD. We have previously demonstrated
the potential for human and porcine MV to generate CPPD
under physiologic ionic conditions unchecked by intact
matrix4,19. Other aspects of degenerating cartilage matrix
which may favor CPPD deposition include increases in ATP
substrate leaked or transported from hypertrophic chondro-
cytes and lower OAMV pyrophosphatase activity22. Taken
together, TGF’s effects on MV NTPPPH activity and
calcium precipitation may increase the potential for imma-
ture CPPD to form in degenerated cartilage matrix. It would
be important to further examine the effects of TGF on
extracellular ATP availability and on other MV enzymes
relevant to ePPi metabolism.
Recent studies implicating apoptosis in the pathogenesis
of OA23 have heightened interest in cartilage vesicle struc-
tures. Previous work supports similarities between MV
and apoptotic bodies (AB) elaborated from sodium
nitroprusside-treated cartilage24. TGF was shown to
increase ePPi generation by AB24, which correlates with
our discovery of TGF-induced increases in MV NTPPPH
activity. Although our experiments did not employ traditional
inducers of apoptosis such as nitric oxide or Fas antibody,
TGF has been shown to induce apoptosis in certain cell
lines25. The effects of TGF in this study may be related to
apoptosis. The quantitative effect of TGF on chondrocyte
apoptosis and subsequent AB mineralization warrants
further investigation.
Osteoarthritis and Cartilage Vol. 9 No. 3 193TGF’s influence on matrix mineralization extends
beyond chondrocyte ePPi elaboration and MV biosynthesis
because of its other complex effects on articular cartilage
matrix homeostasis. TGF increases net matrix proteo-
glycan26 which may either promote27 or inhibit28 calcium
phosphate precipitation in vitro. TGF also decreases
membrane adhesion to type VI collagen, a specifically
localized and abundant constituent of the pericellular
matrix, and decreases expression of chondrocyte 11
integrin, a key mediator of chondrocyte adhesion to type II
collagen29. If unbalanced by other growth factors, TGF
may contribute to the distorted milieu which favors crystal
growth.
Finally, the relationship of MV to TGF appears to be
bidirectional. We recently reported that transglutaminase,
an activator of latent TGF, is associated with PMV30. MV
may therefore provide chondrocytes with the means to
activate the ample latent TGF in articular cartilage matrix.
Degenerating cartilage contains twice the MV/g cartilage
(wet weight) of normal cartilage independent of TGF19.
This increased number of MV could increase latent TGF
activation and thereby increase the capacity of new MV or
chondrocytes to generate ePPi and precipitate calcium.
This amplification pathway may be central to the role of
TGF in CPPD deposition in degenerating cartilage matrix.
In summary, we have demonstrated an additional
mechanism by which TGF may amplify CPPD formation—
beyond its recognized property of stimulating the release of
ePPi by chondrocytes. This study shows that TGF
increased the level of NTPPPH activity released into the
media in the form of MV. MV elaborated by chondrocytes
exposed to TGF also had increased capacity to precipitate
calcium pyrophophate when incubated in the presence of
ATP. This study expands the role of TGF in articular
cartilage biomineralization to include regulation of a
potential nidus for CPPD formation.Acknowledgments
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